Home › Free Stock Grades › EVMN
Evommune, Inc. (EVMN) Stock Grade
EVMN · Healthcare
C
Market Cap
$304.5M
P/E Ratio
—
Revenue Growth (YoY)
+85.7%
Net Margin
-529.8%
Return on Equity
—
Dividend Yield
None
About Evommune, Inc.'s fundamentals
Evommune is a biotechnology company with a market capitalization of $304.5 million that is experiencing rapid revenue expansion, growing 85.7% year-over-year. However, the company is currently unprofitable, operating at a net margin of -529.8%, and reported a net loss in its latest annual statement. The company does not pay a dividend and lacks sufficient profitability to generate meaningful returns on equity.